Bell Investment Advisors’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-19
Closed -$566 1921
2023
Q1
$566 Hold
19
﹤0.01% 1769
2022
Q4
$514 Buy
+19
New +$465 ﹤0.01% 1818
2022
Q3
Sell
-58
Closed -$2K 1721
2022
Q2
$2K Buy
+58
New +$1.67K ﹤0.01% 1089
2021
Q4
$3K Buy
+94
New +$3.04K ﹤0.01% 945

Other funds holding AVNS

Bell Investment Advisors's AVNS Position: Q2 2023 in Review

Bell Investment Advisors sold out of Avanos Medical (AVNS) in Q2 2023, closing a stake of 19 shares — an estimated $566 sold.

Bell Investment Advisors first reported a position in AVNS in Q4 2021 and held it in 4 quarters. The position peaked at $3K in Q4 2021. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2023.

  • Bell Investment Advisors reported no remaining Avanos Medical position as of Q2 2023 after selling out during the quarter.
  • Bell Investment Advisors sold 19 Avanos Medical shares in Q2 2023, an estimated $566.
  • Bell Investment Advisors first reported a position in Avanos Medical in Q4 2021 and held it in 4 quarters.
  • Bell Investment Advisors's Avanos Medical position peaked at $3K in Q4 2021.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2023.

Based on Bell Investment Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.